- 201. Incomplete
- [Not whole; lacking some necessary part or detail; unfinished. ( NCI )] (UMLS (NCI) C0205257) =Quantitative Concept
| - 251. Indicator
- [For attributes representing a specific condition as true or false. ( HL7V3.0 )] (UMLS (HL7) C1554105) =Idea or Concept =MDFAttributeType;
|
- 202. Incomplete Freund's Adjuvant/Interleukin-12/Tyrosinase Related Protein-1
- (UMLS (NCI) C0677823) =Therapeutic or Preventive Procedure ;
| - 252. indicator dilution test
- [methods for assessing flow through a system by injection of a known quantity of an indicator, such as a dye, radionuclide, or chilled liquid, into the system and monitoring its concentration over time at a specific point in the system. ( CSP )] (UMLS (CSP) C0021211) =Laboratory Procedure ;
=cardiovascular disorder diagnosis;
|
- 203. Incomplete Freund's Adjuvant/Interleukin-2/Von Hippel-Lindau Peptide Vaccine
- (UMLS (NCI) C0796338) Incomplete Freund's IFA/IL-2/VHL peptide;
=Therapeutic or Preventive Procedure | - 253. Indigenous/Aboriginal
- (UMLS (HL7) C1549705) =Idea or Concept =Identifier type;
|
- 204. Incomplete Hydatid Mole
- [Derived from the fertilization of an apparently normal ovum by two sperm. Partial hydatidiform moles are characterized by focal chorionic villi swelling, focal trophoblastic hyperplasia, and identifiable fetal or embryonic tissue. Partial moles generally have a triploid karyotype. ( MSH )] (UMLS (NCI) C0334529) =Neoplastic Process
| - 254. Indigenous/Tribal
- [e.g. Chief Red Cloud ( HL7V3.0 )] (UMLS (HL7) C1550441) =Idea or Concept =PersonNameUse;
|
- 205. Incomplete Oophorectomy
- [Surgery that does not remove the entire ovary. This can be by design or by error. ( NCI )] (UMLS (NCI) C0195490) =Therapeutic or Preventive Procedure
| - 255. Indigenous/Tribal/Community Name
- (UMLS (HL7) C1549662) =Idea or Concept =Name type;
|
- 206. Inconsistency between implanted device and implantation procedure
- (UMLS (HL7) C1547482) =Intellectual Product =OCE Edit Code;
| - 256. Indirect
- [Not as a direct effect or consequence; having intervening factors or persons or influences. ( NCI )] (UMLS (NCI) C0439852) =Qualitative Concept ;
|
- 207. Incontinence
- (UMLS (ICPC) C0021167) (Incontinence; GERNU INKONTINENTZIA(ESKL.PSIKOLOG.P12); Urininkontinens (ex P12); Urine incontinentie (ex P12); VIRTSAPIDATYSKYVYTTOMYYS/VIRTSAN KARKAILU (PL P12); Incontinence urinaire (SF P12); Harninkontinenz (ex P12); inkontinentzia shel sheten; incontinencia (kiv. P12); Incontinenza urinaria(escl P12); URININKONTINENS EKS P12; Incontinencia urinaria (excl P12) ; Incontinencia (ex P12); URININKONTINENS (EXKL P12)) Incontinence (excl P12); Incontinence (excluding P12) =Disease or Syndrome ;
=Urologic; Symptoms and Complaints Component | - 257. Indirect exposure mechanism
- (UMLS (HL7) C1547658) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Breast milk;
Father;
Transplacental;
Blood product;
Other;
|
- 208. incontinence
- [failure of voluntary control of the vesical and urethral sphincters, with constant or frequent involuntary passage of urine. ( CSP )] (UMLS (NCI) C0042024) =Disease or Syndrome ;
=Clinical Finding;
urination disorder =Urinary Incontinence, Stress | - 258. Indirect Inguinal Hernia
- (UMLS (NCI) C0019296) =Anatomical Abnormality ;
|
- 209. Incontinence of bowel
- [failure of control of the anal sphincters, with involuntary passage of feces and flatus; it may be either psychogenic or organic in origin.(CSP)] (UMLS (ICPC) C0015732) (Incontinence of bowel; GOROTZ INKONTINENTZIA; Afforingsinkontinens; Incontinentie voor ontlasting; ULOSTEEN PIDATYSKYVYTTOMYYS; Incontinence fecale; Stuhlinkontinenz; inkontinentzia shel tzoa; szeklet incontinencia; Incontinenza intestinale; INKONTINENT FOR AVFORING r15; Incontinencia fecal; Incontinencia intestinal (fecal); AVFORINGSINKONTINENS) =Disease or Syndrome ;
=Body System, Gastrointestinal; Rectal Diseases; Clinical Finding; Symptoms and Complaints Component; anorectal disorder; | - 259. indirect target
- [Target that is not substantially present in the act and which is not directly affected by the act, but which will be a focus of the record or documentation of the act. ( HL7V3.0 )] (UMLS (HL7) C1552011) =Idea or Concept =ParticipationType;
=beneficiary;
record target;
receiver;
coverage target;
holder;
guarantor party |
- 210. Incontinence without sensory awareness
- [ ] (UMLS (ICD9CM) C0375551) =Pathologic Function
| - 260. indirect unit cost
- (UMLS (HL7) C1549766) =Quantitative Concept =Price type;
|
- 211. INCOR DILUT INFUSN FLUID
- [ ] (UMLS (ICD9CM) C0481247) =Injury or Poisoning
| - 261. Indisulam
- [A novel sulfonamide compound with potential antineoplastic activity. Indisulam inhibits cyclin-dependent kinases (CDK), which regulate cell cycle progression and are usually over-expressed in cancerous cells. Inhibition of CDK results in G1/S phase arrest of the cell cycle, and may lead to induction of apoptosis and inhibition of tumor cell proliferation. In addition, indisulam also inhibits carbonic anhydrases (CA), especially isoforms IX and XII that are involved in aqueous humor production and are highly overexpressed in some types of cancers. Inhibition of CA IX and XII results in interference with ion exchange and pH in hypoxic tumor tissue and preventing chemoresistance to weakly basic antineoplastic agents. ( NCI )] (UMLS (NCI) C1099211) N-(3-Chloro-7-indoyl)-1,4-Benzenedisulfonamide;
=Organic Chemical; Pharmacologic Substance ;
|
- 212. incorrect billing
- [The billing information, specified in the Invoice Elements, is not correct. This could include incorrect costing for items included in the Invoice. ( HL7V3.0 )] (UMLS (HL7) C1553699) =Idea or Concept =ActInvoiceCancelReason;
| - 262. INDIUM IN 111 CHLORIDE
- [A radioactive salt that is used as a reagent in the preparation of indium 111-labeled radiopharmaceuticals. Indium 111-labeled radioconjugates are used as radioactive tracers in nuclear medicine that detect malignant lesions and inflammatory tissues probably due to an increased capillary permeability. Indium-111 chloride is particularly used in the radiolabeling of the monoclonal antibodies satumomab pendetide, 7E11-C5.3 (CYT-356), and ibritumomab tiuxetan. (NCI05) ( NCI )] (UMLS (NCI) C0087296) =Indicator, Reagent, or Diagnostic Aid; Inorganic Chemical
|
- 213. incorrect covered party as patient
- [The covered party (patient) specified with the Invoice is not correct. ( HL7V3.0 )] (UMLS (HL7) C1553697) =Idea or Concept =ActInvoiceCancelReason;
| - 263. Indium In 111 Monoclonal Antibody Bre-3/Yttrium Y 90 Monoclonal Antibody Bre-3
- (UMLS (NCI) C0935733) =Therapeutic or Preventive Procedure
|
- 214. incorrect policy
- [The policy specified with the Invoice is not correct. For example, it may belong to another Adjudicator or Covered Party. ( HL7V3.0 )] (UMLS (HL7) C1553698) =Idea or Concept =ActInvoiceCancelReason;
| - 264. Indium Trichloride
- (UMLS (NCI) C0063474) =Inorganic Chemical
|
- 215. incorrect provider
- [The provider specified with the Invoice is not correct. ( HL7V3.0 )] (UMLS (HL7) C1553700) =Idea or Concept =ActInvoiceCancelReason;
| - 265. INDIVID PSYCHOTHERAP NEC
- [ ] (UMLS (ICD9CM) C0029642) =Therapeutic or Preventive Procedure ;
|
- 216. increased
- [Significant change up (quantitative observations, does not imply B or W) ( HL7V3.0 )] (UMLS (HL7) C0205217) =Quantitative Concept =ObservationInterpretationChange;
| - 266. individual
- [Access only to individual persons who are mentioned explicitly as actors of this service and whose actor type warrants that access (cf. to actor type code). ( HL7V3.0 )] (UMLS (HL7) C1550471) =Idea or Concept =ConfidentialityByAccessKind;
|
- 217. Increased Atypical Lymphocytes
- (UMLS (NCI) C0238708) =Finding
| - 267. Individual
- [A single human being. ( NCI )] (UMLS (NCI) C0027361) =Population Group =living subject;
|
- 218. Increased Drug Half Life
- [Increased period of time required for the concentration or amount of drug in the body to be reduced to exactly one-half of a given concentration or amount. ( NCI )] (UMLS (NCI) C1095982) =Finding ;
| - 268. Individual Case Safety Report Sender Type
- [A code that is used to indicate the type of organization which is originating and sending the ICSR. The current code example reference is from the International Conference on Harmonisation (ICH) Expert Workgroup guideline on Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety Reports. Example concepts are: Pharmaceutical Company, Regulatory Authority, Health Professional, Regional Pharmacovigilence Center, World Health Organization Collaborating Center for International Drug Monitoring. ( HL7V3.0 )] (UMLS (HL7) C1699001) =Intellectual Product =EntityCode;
|
- 219. Increased Drug Level
- (UMLS (NCI) C0151599) =Finding
| - 269. Individual Case Safety Report Type
- [A code that is used to indicate the type of case safety report received from sender. The current code example reference is from the International Conference on Harmonisation (ICH) Expert Workgroup guideline on Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety Reports. The unknown/unavailable option allows the transmission of information from a secondary sender where the initial sender did not specify the type of report. Example concepts include: Spontaneous, Report from study, Other. ( HL7V3.0 )] (UMLS (HL7) C1698458) =Intellectual Product ;
=ActCode;
|
- 220. Increased respiratory rate
- [Abnormal increase of rate of breathing. ( NCI )] (UMLS (NCI) C0231835) =Sign or Symptom
| - 270. Individual Case Safety Report Value Domains
- [This domain is established as a parent to a variety of value domains being defined to support the communication of Individual Case Safety Reports to regulatory bodies. Arguably, this aggregation is not taxonomically pure, but the grouping will facilitate the management of these domains. ( HL7V3.0 )] (UMLS (HL7) C1699756) =Classification =ObservationValue;
=DeviceManufacturerEvaluationMethod;
ReactionActionTaken;
CaseSeriousnessCriteria;
Pertinent Reaction Relatedness;
DeviceManufacturerEvaluationInterpretation;
Subject Reaction;
Product Characterization;
SubjectReactionOutcome;
SubjectReactionEmphasis;
DeviceManufacturerEvaluationResult |
- 221. Increased Sputum Excretion
- (UMLS (NCI) C0858642) =Finding
| - 271. Individual psychotherapy
- [ ] (UMLS (ICD9CM) C0204525) =Therapeutic or Preventive Procedure
|
- 222. Increased therapeutic response
- (UMLS (NCI) C0235821) =Finding
| - 272. individuality
- [Those psychological characteristics which differentiate individuals from one another. ( MSH )] (UMLS (CSP) C0021228) =Mental Process ;
|
- 223. incretin hormone
- [insulinotropic peptides released by the gastrointestinal tract in response to food; stimulates insulin secretion and inhibits glucagon secretion. ( CSP )] (UMLS (CSP) C0596770) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone =gastrointestinal hormone;
| - 273. individualized mutant p53 peptide-pulsed cultured autologous dendritic cell vaccine
- [A peptide-based cancer vaccine composed of amino acids 264 to 272 of the wild-type protein encoded by the P53 gene. p53 peptide vaccine may elicit an HLA-A2.1-restricted cytotoxic T lymphocyte immune response against tumor cells that overexpress p53 protein. (NCI04) ( NCI )] (UMLS (NCI) C0879339) P53 (264-272) peptide vaccine and tumor-specific mutant p53 peptide vaccine;
p53 Peptide Vaccine;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor |
- 224. Incus
- [One of three ossicles of the middle ear. It conducts sound vibrations from the MALLEUS to the STAPES. ( MSH )] (UMLS (NCI) C0021181) =Body Part, Organ, or Organ Component ;
| - 274. IndividualPackageEntityType
- [Container intended to contain sufficient material for only one use. ( HL7V3.0 )] (UMLS (HL7) C1699820) =Intellectual Product ;
=RigidContainerEntityType;
=Minim;
Nebuamp;
Ovule;
Ampule |
- 225. IND
- [Status given an experimental drug after the FDA approves an application for testing it in people. ( NCI )] (UMLS (NCI) C0013230) =Pharmacologic Substance
| - 275. indo 1
- [ ] (UMLS (CSP) C0063477) =Organic Chemical; Pharmacologic Substance ;
|
- 226. IND ING HERNIA REP-GRAFT
- (UMLS (ICD9CM) C0176950) =Therapeutic or Preventive Procedure
| - 276. Indocate
- (UMLS (NCI) C0063480) =Organic Chemical; Pharmacologic Substance ;
|
- 227. IND THERAP PSYCHSEX DYSF
- [ ] (UMLS (ICD9CM) C0178061) =Therapeutic or Preventive Procedure
| - 277. Indochina
- [ ] (UMLS (CSP) C0599451) =Geographic Area ;
|
- 228. Indanazoline
- (UMLS (NCI) C0063449) =Organic Chemical; Pharmacologic Substance ;
| - 278. Indochinese American
- [ ] (UMLS (CSP) C0597919) =Population Group ;
|
- 229. Indanidine
- (UMLS (NCI) C0244275) =Organic Chemical; Pharmacologic Substance ;
| - 279. Indocin
- (UMLS (NCI) C0700798) =Organic Chemical; Pharmacologic Substance ;
|
- 230. INDAPAMIDE
- [An indole derivative of chlorosulphonamide and a sulfamyl diuretic with antihypertensive activity. Indapamide may interact directly with the subunits of delayed rectifier potassium channels, thereby blocking both slow and rapid K+ (IKs and IKr) currents through the channels. Through the homeostasis mechanism in balancing total ion concentration (Ca++, Na+), it reduces vascular hyperreactivity and peripheral and arterial vascular resistance, possibly by inhibiting transmembrane ionic influx, probably calcium ions, and stimulating prostaglandin E2 synthesis, thereby causing vasodilatation. Indapamide exerts its diuretic effect by inhibiting reabsorption of sodium and chloride, primarily as a result of action on the cortical diluting segment of the renal distal tubule, thereby promoting urinary excretion of water and electrolytes. ( NCI )] (UMLS (NCI) C0021186) =Organic Chemical; Pharmacologic Substance =[CV701] THIAZIDES/RELATED DIURETICS;
sulfonamide =INDAPAMIDE 1.25 MG;
INDAPAMIDE 2.5 MG;
| - 280. Indocin I.V.
- (UMLS (NCI) C0306457) =Clinical Drug
|
- 231. Indecainide
- (UMLS (NCI) C0063455) =Organic Chemical; Pharmacologic Substance ;
| - 281. INDOCYANINE GREEN
- [tricarbocyanine dye that is used diagnostically in liver function tests and to determine blood volume and cardiac output. ( CSP )] (UMLS (NCI) C0021234) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid =Indole;
cyanine;
[DX101] NON-IONIC CONTRAST MEDIA;
=INDOCYANINE GREEN 50 MG;
INDOCYANINE GREEN 25 MG;
|
- 232. Indecainide Hydrochloride
- (UMLS (NCI) C0771363) =Organic Chemical; Pharmacologic Substance
| - 282. indole
- [bicyclic nitrogenous heterocyclic compounds. ( CSP )] (UMLS (CSP) C0021236) =Organic Chemical ;
=pyrrole;
=phthalocyanin;
SUMATRIPTAN;
tryptamine;
indoleacetate;
indoleamine;
methoxyindole;
pyridoindole |
- 233. Independence
- [Freedom from control or influence of another or others factors. ( NCI )] (UMLS (NCI) C0085862) =Idea or Concept ;
| - 283. Indole
- [Any compound that contains the basic indole structure, an aromatic heterocyclic organic compound, consisting of a six-membered benzene ring fused to a five-membered nitrogen-containing pyrrole ring. ( NCI )] (UMLS (NCI) C0021242) =Organic Chemical ;
=2-Ring Heterocyclic Compound;
=carboline;
ibogaine;
Indigo Carmine;
INDOCYANINE GREEN;
Indoleacetic Acids;
1-(4-chlorobenzoyl)-5-methoxy- 2-methyl-1-H-indole-3-acetic acid;
MAZINDOL;
MOLINDONE;
Dolasetron Mesylate;
SUMATRIPTAN;
TRANDOLAPRIL;
FLUVASTATIN;
Perindopril;
ROPINIROLE;
DELAVIRDINE;
NARATRIPTAN;
|
- 234. independency
- [ ] (UMLS (CSP) C0599749) =Mental Process ;
| - 284. indoleacetate
- [acetate derivatives of the heterocyclic compound indole. ( CSP )] (UMLS (CSP) C0220857) =Organic Chemical; Hormone ;
=indole;
phytohormone =hydroxyindoleacetate;
|
- 235. Independent
- (UMLS (HL7) C1608386) =Idea or Concept =Coordination of Benefits;
◊ (UMLS (HL7) C1549571) Idea or Concept Religious Affiliation; | - 285. indoleamine
- [ ] (UMLS (CSP) C0596771) =Organic Chemical =indole;
|
- 236. Independent Household
- [Independent Household ( HL7V3.0 )] (UMLS (HL7) C1550448) =Idea or Concept =LivingArrangement;
| - 286. indolent
- [(IN-doe-lint) A type of cancer that grows slowly. ( NCI )] (UMLS (NCI) C0234227) =Functional Concept
|
- 237. inderal
- [ ] (UMLS (CSP) C0591636) =Organic Chemical; Pharmacologic Substance
| - 287. Indolent Adult Non-Hodgkin's Lymphoma Stage I
- (UMLS (NCI) C0677682) =Neoplastic Process
|
- 238. inderol
- [ ] (UMLS (CSP) C0920706) =Organic Chemical; Pharmacologic Substance
| - 288. Indolent Adult Non-Hodgkin's Lymphoma Stage III
- (UMLS (NCI) C0677712) =Neoplastic Process ;
|
- 239. Indeterminate Bronchioloalveolar Carcinoma
- [A rare morphologic variant of bronchiolo-alveolar lung carcinoma characterized by the presence of both mucin and non-mucin producing cells. ( NCI )] (UMLS (NCI) C1266036) Mixed Mucinous and Non-Mucinous Bronchioloalveolar Carcinoma;
Mixed Mucinous and Non-Mucinous Bronchioloalveolar Lung Carcinoma;
Mixed Mucinous and Non-Mucinous Bronchoalveolar Lung Carcinoma;
=Neoplastic Process | - 289. Indolent Adult Non-Hodgkin's Lymphoma Stage IV
- (UMLS (NCI) C0677719) =Neoplastic Process ;
|
- 240. INDETERMINATE LEPROSY
- (UMLS (ICD9CM) C0021192) =Disease or Syndrome ;
| - 290. Indolent Clinical Course
- (UMLS (NCI) C1334168) =Finding ;
|
- 241. INDETERMINATE SEX
- (UMLS (ICD9CM) C0021193) =Congenital Abnormality; Disease or Syndrome
| - 291. indolent lymphoma
- [Lymphomas that tend to grow and spread slowly, including chronic lymphocytic lymphoma and follicular small cleaved cell lymphoma. Also called low-grade lymphomas. ( NCI )] (UMLS (NCI) C1334170) Indolent Non-Hodgkin Lymphoma;
Indolent Non-Hodgkin's Lymphoma;
=Neoplastic Process ;
|
- 242. index
- [Refers to a document providing an index for the current document. ( HL7V3.0 )] (UMLS (HL7) C1552854) =Idea or Concept =HtmlLinkType;
| - 292. Indolent Myeloma
- (UMLS (NCI) C1334169) =Neoplastic Process ;
|
- 243. Index
- [A numerical scale used to compare variables with one another or with some reference number; a number used to select an element of a list, vector, array or other sequence. ( NCI )] (UMLS (NCI) C0918012) =Intellectual Product
| - 293. Indolent Systemic Mastocytosis
- [A form of systemic mastocytosis in which patients experience no pain. It is characterized by the multifocal mast cell filtrates, mostly in skin and bone marrow (] (UMLS (NCI) C0272203) =Disease or Syndrome
|
- 244. indexing
- [assigning of descriptors for referencing documents. ( CSP )] (UMLS (CSP) C0021200) =Occupational Activity ;
=classification;
| - 294. indolizine
- [ ] (UMLS (CSP) C0021243) =Organic Chemical ;
=pyridine;
=(+)-Camptothecin |
- 245. Indian Mulberry Extract
- [An extract prepared from the fruit of Morinda citrifolia, a plant that yields various herbal preparations. Morinda citrifolia fruit juice has antioxidant properties and may prevent tumorigenesis via inhibition of DNA-carcinogen adduct formation. ( NCI )] (UMLS (NCI) C1328724) Morinda citrifolia Extract;
Morinda Citrifolia Fruit Extract;
Noni;
Noni Extract;
Noni Juice =Pharmacologic Substance; ;
| - 295. Indomethacin Sodium
- [The sodium salt of indomethacin, a methylated indole derivative with anti-inflammatory, analgesic-antipyretic and tocolytic effects. Indomethacin is a non-selective, reversible, and competitive inhibitor of cyclooxygenases 1 and 2, thereby blocking the conversion of arachidonic acid into prostaglandin precursors. Consequently, prostaglandin synthesis is decreased, and prostaglandin-mediated activities are prevented, including pain, inflammation, fever and uterine contraction. ( NCI )] (UMLS (NCI) C0982211) INDOMETHACIN SODIUM PREPARATION;
=Organic Chemical; Pharmacologic Substance ;
=1-(4-chlorobenzoyl)-5-methoxy- 2-methyl-1-H-indole-3-acetic acid;
[CV900] CARDIOVASCULAR AGENTS, OTHER =INDOMETHACIN SODIUM 1 MG |
- 246. Indian Rupee
- [Indian Rupee, monetary currency of India ( HL7V3.0 )] (UMLS (HL7) C1555427) =Quantitative Concept =Currency;
| - 296. Indonesian
- [Denotes the inhabitants of Indonesia, a person from there, or their descendants elsewhere. ( NCI )] (UMLS (NCI) C0337900) =Population Group ;
=Asian;
|
- 247. Indicates a percent change
- (UMLS (HL7) C1549030) =Idea or Concept =Computation type;
| - 297. Indonesian American
- [ ] (UMLS (CSP) C0597920) =Population Group ;
|
- 248. Indication
- [A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication). ( NCI )] (UMLS (NCI) C0392360) =Idea or Concept ;
| - 298. INDORAMIN
- [A hypotensive agent with some anti-arrhythmic effects. ( MSH )] (UMLS (NCI) C0021252) =Organic Chemical; Pharmacologic Substance
|
- 249. Indication For Use
- (UMLS (HL7) C1547884) =Idea or Concept =HL7 Vocabulary Version 2.5;
| - 299. Induce
- [The act of bringing about something. ( NCI )] (UMLS (NCI) C0205263) =Functional Concept
|
- 250. IndicationValue
- [Indicates the specific observation result which is the reason for the action (prescription, lab test, etc.). E.g. Headache, Ear infection, planned diagnostic image (requiring contrast agent), etc. ( HL7V3.0 )] (UMLS (HL7) C1698556) =Qualitative Concept =ObservationValue;
| - 300. induced hyperthermia
- [Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation (heat waves, infra-red), ultrasound, or drugs. ( MSH )] (UMLS (CSP) C0020548) =Therapeutic or Preventive Procedure
|
home
